Loading fund…
Loading fund…
| Returns | 1D | 1M | 3M | YTD | 1Y | 3Y | 5Y | MAX |
|---|---|---|---|---|---|---|---|---|
| Total return | ▲ +0.2% | ▼ −4.4% | ▲ +3.1% | — | — | — | — | ▲ +0.1% |
| Peer average | ▲ +1.2% | ▲ +4.5% | ▲ +9.5% | ▲ +22.6% | ▲ +30.8% | ▲ +76.1% | ▲ +30.8% | — |
| S&P 500 · VOO | ▼ −0.4% | ▲ +0.9% | ▲ +3.3% | ▲ +13.8% | ▲ +13.3% | ▲ +88.8% | ▲ +81.9% | — |
Reported holdings are shown below. A share-of-fund chart is unavailable for this portfolio.
Holdings as of 2026-10-30. Derivatives are shown using their reported instrument names.
| Holding | Instrument | Weight |
|---|---|---|
| US Dollars | Reported holding | 55.87% |
| US TBill 04/22/2027 | Reported holding | 38.23% |
| US TBill 02/04/2027 | Reported holding | 6.43% |
| 2LABU 11/04/2026 P228.74 | Reported holding | 0.49% |
| 2LABU 11/02/2026 P201.14 | Reported holding | 0.11% |
| 2LABU 10/30/2026 P197.64 | Reported holding | 0.00% |
| 2LABU 10/30/2026 P208.62 | Reported holding | -0.01% |
| 2LABU 11/02/2026 P212.32 | Reported holding | -0.22% |
| 2LABU 11/04/2026 P241.44 | Reported holding | -0.90% |
The GraniteShares YieldBOOST Biotech ETF, an exchange-traded fund launched by GraniteShares Inc. under the umbrella of the GraniteShares ETF Trust, is managed by GraniteShares Advisors LLC. This U.S.-domiciled fund primarily allocates capital to the public stock markets within the United States. Its investment approach involves constructing its portfolio using derivative instruments, such as options, to gain exposure to companies operating across the healthcare, pharmaceutical, biotechnology, and life sciences industries. The ETF seeks a diverse selection of both growth and value stocks, encompassing businesses of varying market capitalizations.
Distribution yield and SEC yield use different methodologies. Payouts may include income, capital gains, or return of capital.
| Ex-date | Pay date | Per share |
|---|---|---|
| 2026-10-30 | 2026-11-03 | $0.23 |
| 2026-10-23 | 2026-10-27 | $0.23 |
| 2026-10-16 | 2026-10-20 | $0.23 |
| 2026-10-09 | 2026-10-14 | $0.23 |
| 2026-10-02 | 2026-10-06 | $0.23 |
| 2026-09-25 | 2026-09-29 | $0.23 |
| 2026-09-18 | 2026-09-22 | $0.23 |
| 2026-09-11 | 2026-09-15 | $0.25 |
| 2026-09-04 | 2026-09-09 | $0.25 |
| 2026-08-28 | 2026-09-01 | $0.25 |
| 2026-08-21 | 2026-08-25 | $0.25 |
| 2026-08-14 | 2026-08-18 | $0.25 |
Estimated annual expense excludes trading costs and assumes constant assets. Fee waivers and fund costs can change.
Historical risk measures describe past behavior and do not predict future returns.
Hear the strategy from the people behind BIOY.